Literature DB >> 15325797

Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs).

Elisabeth Guinet1, Keiichiro Yoshida, Mahyar Nouri-Shirazi.   

Abstract

Differentiation of tissue monocytes into DCs is a critical phase in the development of a competent immune system. We show that in a nicotinic environment, while human monocytes differentiate into DCs (henceforth called nicDCs) with a typical morphology, they display unique phenotype and cytokine profile that adversely affect their function. Despite an increased capacity for receptor-dependent antigen uptake, nicDCs do not express CD1a and fail to fully up-regulate MHCs, molecules essential for their antigen-presenting function. Additionally, in response to bacterial antigen LPS, maturing nicDCs hardly express the chemotactic cytokine receptor 7 required for their entry into lymphatic vessels. Furthermore, in parallel with their differential expression of costimulatory molecules CD80 and CD86 and lack of IL-12, nicDCs display profoundly reduced Th1 promoting capacity. These findings thus indicate that nicotine impedes the development of cell-mediated immunity by skewing DC differentiation. These effects of nicotinic environment on DC differentiation may contribute to the increased risks of respiratory tract infection and various cancers in smokers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325797     DOI: 10.1016/j.imlet.2004.06.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  21 in total

Review 1.  Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.

Authors:  Wen-Yan Cui; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

2.  Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation.

Authors:  Mahyar Nouri-Shirazi; Saba Tamjidi; Erika Nourishirazi; Elisabeth Guinet
Journal:  Int Immunopharmacol       Date:  2018-05-24       Impact factor: 4.932

3.  Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7.

Authors:  H Yoshikawa; M Kurokawa; N Ozaki; K Nara; K Atou; E Takada; H Kamochi; N Suzuki
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 4.  Common innate pathways to autoimmune disease.

Authors:  David Langan; Noel R Rose; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2020-02-10       Impact factor: 3.969

5.  Low IL-10/TNFα ratio in patients with coronary artery disease and reduced left ventricular ejection fraction with a poor prognosis after 10 years.

Authors:  Jörn F Dopheide; Pascal Knopf; Geraldine C Zeller; Markus Vosseler; Nico Abegunewardene; Thomas Münzel; Christine Espinola-Klein
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

6.  Thirdhand smoke component can exacerbate a mouse asthma model through mast cells.

Authors:  Mang Yu; Kaori Mukai; Mindy Tsai; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2018-04-18       Impact factor: 10.793

7.  Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anti-cyclic citrullinated peptide antibodies.

Authors:  Hua Yu; Ying-Hua Yang; Rajesh Rajaiah; Kamal D Moudgil
Journal:  Arthritis Rheum       Date:  2011-04

Review 8.  Nicotine and inflammatory neurological disorders.

Authors:  Wen-Hua Piao; Denise Campagnolo; Carlos Dayao; Ronald J Lukas; Jie Wu; Fu-Dong Shi
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

9.  Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses.

Authors:  Robert Vassallo; Paula R Kroening; Joseph Parambil; Hirohito Kita
Journal:  Mol Immunol       Date:  2008-06-03       Impact factor: 4.407

Review 10.  The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.

Authors:  W J de Jonge; L Ulloa
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.